Surge in pre-emptive requests for abortion pills in US amidst legal uncertainty: Study
HQ Team January 3, 2024: The aftermath of the Supreme Court’s Dobb decision on abortion rights has seen a significant rise in pre-emptive
HQ Team January 3, 2024: The aftermath of the Supreme Court’s Dobb decision on abortion rights has seen a significant rise in pre-emptive
HQ Team January 3, 2023: Voyager Therapeutics, Inc., will receive an upfront payment of $100 million from Switzerland-based Novartis AG to develop gene
By Dr K. Leelamoni January 3, 2024: I started fretting a month ago when my friend Radhika stopped answering my cellphone calls. She
HQ Team January 2, 2024: After screening 12 million commercially available compounds using AI, researchers at the Massachusetts Institute of Technology have discovered
HQ Team January 1, 2024: As the conflict in Gaza rages on, a dual crisis emerges, with infectious diseases and hunger posing severe
HQ team January 1, 2024: A new study done by the Weizmann Institute of Science in Israel looks into how human female tears
HQ Team January 1, 2024: Smoking is injurious to health is an accepted fact by smokers even, and figures say that nine out
By K. Leelamoni The coronavirus variant JN. 1 has been causing concern among health experts and the public alike. JN.1 is surging in
HQ Team December 23, 2023: Moderna unveiled a skin cancer vaccine that demonstrated promising results in recent clinical trials. The vaccine, administered in
HQ Team December 23, 2023: Bristol Myers Squibb will buy US-based biotech company, Karuna Therapeutics for $14 billion to expand its neuroscience portfolio,